QQ客服 官方微博 反馈留言

	Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer
	Duan, Jianchun; Yang, Zhenhua; Liu, Dingyuan; Zhang, Zhen; Shi, Yunfei
	2018
卷号	23期号:5页码:1402-1406
关键词	advanced non-small cell lung cancer bevacizumab survival rate clinical effect GP chemotherapy
ISSN号	1107-0625
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6354568
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Duan, Jianchun,Yang, Zhenhua,Liu, Dingyuan,et al. Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer[J],2018,23(5):1402-1406.
APA	Duan, Jianchun,Yang, Zhenhua,Liu, Dingyuan,Zhang, Zhen,&Shi, Yunfei.(2018).Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.,23(5),1402-1406.
MLA	Duan, Jianchun,et al."Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer".23.5(2018):1402-1406.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。